Back to search
FDAFDA · Food and drugs·Recall number D-0440-2024

Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10

Published April 17, 2024 · Recall initiated: February 15, 2024

Summary

FDA records drug Class I recall D-0440-2024, published April 17, 2024 and initiated February 15, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 1,552 10ml x 25/carton; Lot: Lot #: 3MC23011, Exp 11/30/2026. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter

What to do

Voluntary: Firm initiated · Letter

Get an email if METHOCARBAMOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METHOCARBAMOL
Manufacturer
Eugia US LLC
Distributor
Nationwide in the USA
Lot
Lot #: 3MC23011, Exp 11/30/2026
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10 recalled?

Yes. FDA published recall D-0440-2024 on April 17, 2024. Reported hazard: Presence of Particulate Matter

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METHOCARBAMOL.